[Effect and therapy in the control of thrombocyte-induced hemorrhage with phospholipids (exemplified by Fibraccel)].
D001779:Blood Coagulation Factors / Q000378:metabolism; D006470:Hemorrhage / Q000097:blood / Q000628:therapy*; D006801:Humans; D010743:Phospholipids / Q000097:blood / Q000627:therapeutic use*; D010976:Platelet Count / Q000187:drug effects; D010977:Platelet Factor 3 / Q000378:metabolism; D010978:Platelet Factor 4 / Q000378:metabolism; D010979:Platelet Function Tests; D013921:Thrombocytopenia / Q000097:blood / Q000628:therapy*
D001779:Blood Coagulation Factors; D010743:Phospholipids; D010977:Platelet Factor 3; D010978:Platelet Factor 4
Wirkung und Therapie zur Stillung thrombozytär bedingter Blutungen mit Phospholipiden (z. B. Fibraccel).